Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Invex Therapeutics Ltd ABN/ARBN Financial year ended: 29 632 145 334 30 June 2026 ...